Pharmaceutical research, Scientist preparing a sample vial for analytical testing in the laboratory

Aegis adopts genotyping approach to track SARS-CoV-2 variants through NIH funded project

Under contracts with NIH, testing laboratories at Aegis Sciences Corporation, Nashville; Helix, San Diego; and the University of Washington Medical Center, Seattle, have adopted the genotyping approach and are contributing data to the ROSALIND Tracker. This tracking tool—the ROSALIND Tracker for COVID-19 is a free, public dashboard that displays state-by-state the positivity rate and percentage of each variant in circulation, illustrating how genotyping and sequencing work hand in hand as part of the surveillance framework. 

Read full press release: NIH-funded project offers efficient approach when tracking SARS-CoV-2 variants